Lucid Diagnostics

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$1,211,000
$1,163
$828
$1,197
Gross Profit
-486,000
-622
-723
-948
EBITDA
-9,954,221
-4,211
-26,678
-11,312
EBIT
-10,395,000
-4,433
-26,899
-11,534
Net Income
-10,397,000
-4,439
-26,908
-11,541
Net Change In Cash
1,211,000
1,163
828
1,197
Free Cash Flow
-10,921
-10,574
-12,558
-10,130
Cash
47,332
31,123
25,238
22,358
Basic Shares
108,176
98,989
68,796
57,705

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$4,346
$2,428
$377
$500
Gross Profit
-3,920
-6,050
-3,237
-85
EBITDA
-44,336
-49,751
-54,235
-27,415
EBIT
-45,503
-52,250
-56,171
-27,419
Net Income
-45,529
-52,666
-56,171
-28,078
Net Change In Cash
4,346
2,428
377
500
Cost of Revenue
-31,182
Free Cash Flow
-44,786
-33,038
-30,593
-18,530
Cash
22,358
18,896
22,474
53,656
Basic Shares
50,516
41,756
36,172
36,057

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
-$0.10
2025-06-30
-$0.10
2025-03-31
-$0.16